Clinical Professor of Medicine
Department of Medicine
University of California San Francisco (UCSF)
Helen Diller Family Comprehensive Cancer Center
San Francisco, CA
Dr. Melisko is a Clinical Professor of Medicine at the University of California San Francisco Helen Diller Family Comprehensive Cancer Center. She is interested in testing novel chemotherapy combinations, biological therapies and immunotherapies for breast cancer, with an emphasis on therapies to treat central nervous system metastases. Dr. Melisko has conducted studies evaluating clinical and molecular markers that predict the development of and prognosis after diagnosis of brain metastases, has investigated assays to diagnose and assess response to leptomeningeal carcinomatosis, and reported on molecular signatures of tumor cells in the cerebrospinal fluid. She has been a principal investigator for multiple investigator initiated and industry sponsored clinical trials in metastatic breast cancer and CNS disease.
Dr. Melisko is co leader of the Patient Reported Outcomes working group in the Translational Breast Cancer Research Consortium and helped develop and lead the Quality of Life/Patient Reported Outcomes within the ISPY neoadjuvant clinical trial. She is the medical director of the UCSF Breast Cancer Survivorship Program and has led trials on quality of life and lifestyle change in breast cancer patients. She is an active member of the NCCN Survivorship Guideline Committee.
Dr. Melisko graduated from Duke University, received her MD from the Wake Forest University School of Medicine, completed residency in internal medicine at Stanford University Hospital and fellowship in hematology and oncology at UCSF.
